Rising Needle stick Injuries and Infections | Driving The Growth Of Needles Market

The Major factors driving the growth Of Needles Market

The growing geriatric population, increasing number of hospitals in emerging markets, high prevalence of chronic diseases, and increasing demand for vaccines, the rising needlestick injuries and infections, use of needle-free technology, and growing focus on the development of alternative drug delivery methods .

 The global needles market is projected to reach USD 8.47 Billion by 2022 from USD 5.82 Billion in 2017, at a CAGR of 7.8% during the forecast period.

Key Players :

A majority of the leading players, including Medtronic plc (Ireland), Ethicon US, LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), and Boston Scientific Corporation (U.S.), among others in the needles market are developing advanced needles enabled with safety features to secure their position in the market. Companies also focus on upgrading their product offerings and expanding their distribution networks to gain a larger share of the market through partnerships and collaborations.

Get PDF Brochure Here : http://bit.ly/2vlMHRm

Based on product, the needles market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and other needles. The pen needles segment is expected to hold the largest share of the needles market in 2017. The demand for pen needles is expected to increase with the growing prevalence of diabetes. Around 415 million people had diabetes in 2013, worldwide; by 2040, this figure is expected to increase to 642 million (Source: International Diabetes Federation). Thus, with the increasing prevalence of diabetes across the globe, the demand for pen needles will increase during the forecast period.

On the basis of the delivery mode, the needles market is segmented into hypodermic, intravenous, intramuscular, and intraperitoneal needles. The hypodermic needles segment is expected to account for the largest share of the needles market in 2017. These needles are used for injecting drugs into the subcutaneous layer of skin; this enables the quick absorption of active compounds into the bloodstream, which is the key factor contributing to the market growth of this segment.

This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the global needles market. In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the global needles industry.

To Know More : http://bit.ly/2wKO0ah